{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:26:51Z","timestamp":1787772411722,"version":"build-2784847793"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Twenty nail dystrophy refers to the condition of trachyonychia affecting all the twenty nails. The term trachyonychia is used to describe thin brittle nails with excessive longitudinal ridging. Treatment of twenty nail dystrophy is difficult due to poor bioavailability of drugs in nails. Tofacitinib is novel JAK-STAT inhibitor that has been used successfully for the treatment of nail dystrophy with alopecia areata suggests the possibility of the drug being used for twenty nail dystrophy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijd.ijd_492_22","type":"journal-article","created":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T12:15:14Z","timestamp":1716984914000},"page":"725-727","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Tofacitinib for the Treatment of Twenty-Nail Dystrophy"],"prefix":"10.4103","volume":"67","author":[{"given":"Vineet","family":"Dube","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Bhushan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-17-20240829","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/j.1365-2133.1994.tb08591.x","article-title":"Idiopathic trachyonychia (twenty-nail dystrophy): A pathological study of 23 patients","volume":"131","author":"Tosti","year":"1994","journal-title":"Br J Dermatol"},{"key":"R2-17-20240829","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1365-2133.1979.tb05650.x","article-title":"Trachyonychia (Rough nails)","volume":"101","author":"Samman","year":"1979","journal-title":"Br J Dermatol"},{"key":"R3-17-20240829","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1001\/jamadermatol.2015.3772","article-title":"Tofacitinib citrate for the treatment of nail dystrophy associated with alopecia universalis","volume":"152","author":"Dhayalan","year":"2016","journal-title":"JAMA Dermatol"},{"key":"R4-17-20240829","doi-asserted-by":"crossref","first-page":"386","DOI":"10.4103\/0378-6323.18941","article-title":"Nail changes and disorders among the elderly","volume":"71","author":"Singh","year":"2005","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R5-17-20240829","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.0105-1873.2006.0560e.x","article-title":"Occupational trachyonychia due to psoriasis: Report of a case successfully treated with oral acitretin","volume":"54","author":"Tosti","year":"2006","journal-title":"Contact Dermatitis"},{"key":"R6-17-20240829","first-page":"202","article-title":"Trachyonychia treated with oral mini pulse therapy","volume":"67","author":"Mittal","year":"2001","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R7-17-20240829","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1159\/000246333","article-title":"Dynamics of psoriatic trachyonychia during low-dose cyclosporine A treatment: A pilot study on onychochronobiology using optical profilometry","volume":"192","author":"Pierard","year":"1996","journal-title":"Dermatology"},{"key":"R8-17-20240829","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1365-2230.2005.01737.x","article-title":"Treatment of trachyonychia with tazarotene","volume":"30","author":"Soda","year":"2005","journal-title":"Clin Exp Dermatol"},{"key":"R9-17-20240829","first-page":"27","article-title":"Topical 5-fluorouracil treatment for psoriatic trachyonychia","volume":"62","author":"Schissel","year":"1998","journal-title":"Cutis"},{"key":"R10-17-20240829","first-page":"1027","article-title":"Nail lichen planus in children: Clinical features, response to treatment, and long term follow-up","volume":"137","author":"Tosti","year":"2001","journal-title":"Arch Dermatol"},{"key":"R11-17-20240829","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.autrev.2014.10.014","article-title":"The autoimmune basis of alopecia areata: A comprehensive review","volume":"14","author":"Islam","year":"2015","journal-title":"Autoimmun Rev"},{"key":"R12-17-20240829","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/nm.3645","article-title":"Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition","volume":"20","author":"Xing","year":"2014","journal-title":"Nat Med"},{"key":"R13-17-20240829","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jaad.2016.12.004","article-title":"Janus kinase inhibitors in dermatology: A systematic review","volume":"76","author":"Shreberk-Hassidim","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"R14-17-20240829","first-page":"914","article-title":"An excellent response to tofacitinib in a pediatric alopecia patient: A Case report and review","volume":"17","author":"Brown","year":"2018","journal-title":"J Drugs Dermatol"},{"key":"R15-17-20240829","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jaad.2016.09.006","article-title":"Tofacitinib for the treatment of alopecia areata and variants in adolescents","volume":"76","author":"Craiglow","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"R16-17-20240829","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1159\/000450848","article-title":"Remarkable improvement of nail changes in alopecia areata universalis with 10 months of treatment with tofacitinib: A case report","volume":"8","author":"Ferreira","year":"2016","journal-title":"Case Rep Dermatol"},{"key":"R17-17-20240829","doi-asserted-by":"crossref","first-page":"32","DOI":"10.4103\/ijt.ijt_91_21","article-title":"Recovery of alopecia universalis with associated nail dystrophy treated with tofacitinib: A 6-year-old child's case report","volume":"13","author":"Dube","year":"2021","journal-title":"Int J Trichology"},{"key":"R18-17-20240829","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1001\/jamadermatol.2020.4555","article-title":"Tofacitinib as treatment for nail lichen planus associated with alopecia universalis","volume":"157","author":"Iorizzo","year":"2021","journal-title":"JAMA Dermatol"}],"container-title":["Indian Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijd.ijd_492_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:45:13Z","timestamp":1787769913000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijd.ijd_492_22"}},"subtitle":["A Single Case Report"],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/ijd.ijd_492_22","relation":{},"ISSN":["0019-5154"],"issn-type":[{"value":"0019-5154","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]}}}